Thrombophilia is a predisposition to develop thrombosis due to genetic, environmental causes, or a combination of both.
This test analyzes 12 genetic variants in 7 key coagulation genes, related to the risk of venous thromboembolic disease (VTE).
It is estimated that one-third of patients with congenital thrombophilia have their first thrombosis episode in situations of added risk, such as pregnancy. Timely identification of women with a higher predisposition can help prevent complications such as preeclampsia, recurrent miscarriages, or implantation failures.
In addition to the genetic analysis, the test includes a unique risk algorithm that integrates clinical and genetic data, along with a personalized medical report with practical recommendations.